.psi..epsilon.rack peptide composition and method for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2429108

A method of reducing damage to cells and tissue caused by an ischemic or hypoxic event is disclosed. The method includes administering to the cell or tissue, either in vivo or ex vivo, .psi..epsilon.RACK peptide. The peptide can be administered before, during or after the ischemic or hypoxic event.

L'invention concerne un procédé destiné à réduire les dommages causés aux cellules et aux tissus par un événement ischémique ou hypoxique. Ce procédé consiste à administrer aux cellules ou aux tissus, <i>in vivo</i> ou <i>ex vivo</i>, un peptide .psi..epsilon.RACK. Ce peptide peut être administré avant, pendant ou après un événement ischémique ou hypoxique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

.psi..epsilon.rack peptide composition and method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with .psi..epsilon.rack peptide composition and method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .psi..epsilon.rack peptide composition and method for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1833298

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.